Go to previous versions
of
this Statute
2022 Nevada Revised Statutes
Chapter 422 - Health Care Financing and Policy
NRS 422.27235 - State Plan for Medicaid: Inclusion of requirement for payment of certain costs related to preventing acquisition of human immunodeficiency virus.
Universal Citation: NV Rev Stat § 422.27235 (2022)
The Director shall include in the State Plan for Medicaid a requirement that the State pay the nonfederal share of expenditures incurred for:
1. Any laboratory testing that is necessary for therapy that uses a drug approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus; and
2. The services of a pharmacist described in NRS 639.28085. The State must provide reimbursement for such services at a rate equal to the rate of reimbursement provided to a physician, physician assistant or advanced practice registered nurse for similar services.
(Added to NRS by 2021, 3204)
Disclaimer: These codes may not be the most recent version. Nevada may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
